You might be interested in
2024 Preview
What’s in store for 2024: EZZ Life Science
On the Bid
Life Sciences: Accelerating innovation, personalised healthcare and the pandemic impact
Health & Biotech
Stockhead TV
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Sarah Hughan tells all on EZZ Life Science (ASX:EZZ) planting its flag in the US after achieving crucial FDA approval for nine of its products in the food category.
Last year saw the online sales of health supplements in The States climb to nearly US$24B.
Tune in to get the latest.
While EZZ Life Science is a Stockhead advertiser, it did not sponsor this article.